Tri-Heal (TB-500 25 mg + BPC-157 10 mg + KPV 10 mg Vial) Dosage Protocol
Contents
Quickstart Highlights
Tri-Heal is a research peptide blend combining TB-500 (25 mg), BPC-157 (10 mg), and KPV (10 mg) for advanced tissue repair and inflammation modulation[1]. TB-500 is a synthetic fragment of thymosin β4, a 43-amino-acid peptide involved in cell migration, angiogenesis, and wound healing[2]. BPC-157 is a synthetic 15-amino-acid body protection compound with pro-angiogenic and gastroprotective properties[3]. KPV (Lys-Pro-Val) is a tripeptide derived from α-MSH noted for potent anti-inflammatory effects[4]. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.
- Reconstitute: Add 3.0 mL bacteriostatic water → 15 mg/mL concentration (15,000 mcg/mL).
- Typical daily range: 500–2000 mcg once daily (gradual titration over 8 weeks).
- Easy measuring: At 15 mg/mL, 1 unit = 0.01 mL = 150 mcg on a U-100 insulin syringe.
- Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles[5].
-300x300.webp)
Dosing & Reconstitution Guide
Standard 8-Week Protocol (3 mL = 15 mg/mL)
| Week | Daily Dose (mcg) | Daily Dose (mg) | Units (per injection) | Volume (mL) |
|---|---|---|---|---|
| Weeks 1–2 | 500 mcg | 0.5 mg | 3.3 units* | 0.033 mL |
| Weeks 3–4 | 1000 mcg | 1.0 mg | 6.7 units* | 0.067 mL |
| Weeks 5–6 | 1500 mcg | 1.5 mg | 10 units | 0.10 mL |
| Weeks 7–8 | 2000 mcg | 2.0 mg | 13.3 units | 0.133 mL |
*Precision Note: For doses ≤10 units (≤0.10 mL), consider using 30-unit or 50-unit insulin syringes for improved readability and accuracy.
Frequency: Inject once daily subcutaneously[6]. This schedule uses the largest practical dilution (3.0 mL) to optimize syringe accuracy across all dose levels.
Extended 12-Week Protocol (3 mL = 15 mg/mL)
| Week | Daily Dose (mcg) | Daily Dose (mg) | Units (per injection) | Volume (mL) |
|---|---|---|---|---|
| Weeks 1–2 | 500 mcg | 0.5 mg | 3.3 units* | 0.033 mL |
| Weeks 3–4 | 1000 mcg | 1.0 mg | 6.7 units* | 0.067 mL |
| Weeks 5–6 | 1500 mcg | 1.5 mg | 10 units | 0.10 mL |
| Weeks 7–8 | 2000 mcg | 2.0 mg | 13.3 units | 0.133 mL |
| Weeks 9–10 | 2500 mcg | 2.5 mg | 16.7 units | 0.167 mL |
| Weeks 11–12 | 3000 mcg | 3.0 mg | 20 units | 0.20 mL |
Extended 16-Week Protocol (3 mL = 15 mg/mL)
| Week | Daily Dose (mcg) | Daily Dose (mg) | Units (per injection) | Volume (mL) |
|---|---|---|---|---|
| Weeks 1–2 | 500 mcg | 0.5 mg | 3.3 units* | 0.033 mL |
| Weeks 3–4 | 1000 mcg | 1.0 mg | 6.7 units* | 0.067 mL |
| Weeks 5–6 | 1500 mcg | 1.5 mg | 10 units | 0.10 mL |
| Weeks 7–8 | 2000 mcg | 2.0 mg | 13.3 units | 0.133 mL |
| Weeks 9–10 | 2500 mcg | 2.5 mg | 16.7 units | 0.167 mL |
| Weeks 11–12 | 3000 mcg | 3.0 mg | 20 units | 0.20 mL |
| Weeks 13–14 | 3500 mcg | 3.5 mg | 23.3 units | 0.233 mL |
| Weeks 15–16 | 4000 mcg | 4.0 mg | 26.7 units | 0.267 mL |
Reconstitution Steps
- Draw 3.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming or direct stream onto the lyophilized cake.
- Gently swirl or roll until fully dissolved (do not shake vigorously).
- Label with date and concentration (15 mg/mL); refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Plan based on an 8–16 week daily protocol with gradual titration.
- Peptide Vials (Tri-Heal, 45 mg each):
- 8 weeks (56 doses, ~70 mg total): 2 vials
- 12 weeks (84 doses, ~147 mg total): 4 vials
- 16 weeks (112 doses, ~252 mg total): 6 vials
- Insulin Syringes (U-100):
- Per week: 7 syringes (1/day)
- 8 weeks: 56 syringes
- 12 weeks: 84 syringes
- 16 weeks: 112 syringes
Recommendation: Include 30-unit or 50-unit syringes for the early low-dose phases (Weeks 1–4) where precision is critical.
- Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
- 8 weeks (2 vials): 6 mL → 1 × 10 mL bottle
- 12 weeks (4 vials): 12 mL → 2 × 10 mL bottles
- 16 weeks (6 vials): 18 mL → 2 × 10 mL bottles
- Alcohol Swabs: One for the vial stopper + one for the injection site each day.
- Per week: 14 swabs (2/day)
- 8 weeks: 112 swabs → recommend 2 × 100-count boxes
- 12 weeks: 168 swabs → recommend 2 × 100-count boxes
- 16 weeks: 224 swabs → recommend 3 × 100-count boxes
Protocol Overview
Concise summary of the once-daily regimen.
- Goal: Support tissue repair, regeneration, and inflammation modulation through synergistic peptide action[2][3][4].
- Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
- Dose Range: 500–4000 mcg daily with gradual titration.
- Reconstitution: 3.0 mL per 45 mg vial (15 mg/mL) for accurate unit measurements.
- Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw[5].
Dosing Protocol
Suggested daily titration approach.
- Start: 500 mcg daily; increase by 500 mcg every 2 weeks as tolerated.
- Target: 1500–2000 mcg daily by Weeks 5–8 (standard); up to 3000–4000 mcg for extended protocols.
- Frequency: Once per day (subcutaneous).
- Cycle Length: 8–12 weeks; optional extension to 16 weeks.
- Timing: Any consistent time; rotate injection sites systematically.
Storage Instructions
Proper storage preserves peptide quality and potency.
- Lyophilized: Store at −20 °C (−4 °F) or colder (ideally −80 °C / −112 °F for long-term) in dry, dark conditions[5].
- Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 4 weeks; prepare aliquots if needed and avoid freeze–thaw cycles[5].
- Allow vials to reach room temperature before opening to reduce condensation uptake.
Important Notes
Practical considerations for consistency and safety.
- Use new sterile insulin syringes for each injection; dispose in a sharps container.
- Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation and prevent lipohypertrophy[6].
- Inject slowly; wait a few seconds before withdrawing the needle.
- Document daily dose, site rotation, and any observations to maintain consistency.
- For doses under 10 units, use 30-unit or 50-unit insulin syringes for improved accuracy.
How This Works
Tri-Heal combines three peptides with complementary mechanisms targeting multiple aspects of tissue injury repair:
TB-500 (Thymosin β4): Acts as a natural repair factor, inhibiting inflammation and apoptosis while promoting angiogenesis, cell migration, and matrix remodeling[2][7]. This 43-amino-acid peptide has been shown to accelerate dermal healing in both preclinical models and clinical applications[2].
BPC-157 (Body Protection Compound): Enhances healing via VEGFR2/Akt-eNOS activation, increasing nitric oxide production and angiogenesis while stimulating fibroblast activity[8]. This 15-amino-acid gastric peptide accelerates tendon, muscle, and gut repair[3][9].
KPV (Lys-Pro-Val): Provides anti-inflammatory effects by reducing NF-κB activation and attenuating pro-inflammatory cytokine signaling in epithelial and immune cells[4]. This α-MSH-derived tripeptide complements the regenerative actions of TB-500 and BPC-157.
The combination thus addresses wound repair, angiogenesis, and inflammation simultaneously through distinct but synergistic pathways.
Potential Benefits & Side Effects
Observations from preclinical and clinical literature on the individual components.
- TB-500: Promotes cell proliferation, angiogenesis, and accelerated tissue repair; inhibits apoptosis and inflammation in healing tissues[2][7].
- BPC-157: Accelerates musculoskeletal healing including tendon and muscle repair; stimulates endothelial regeneration and fibroblast activity[3][9].
- KPV: Reduces inflammatory cytokine release; demonstrates efficacy in models of epithelial inflammation[4].
- General tolerability: Individual peptides are generally well tolerated in preclinical studies; occasional mild injection-site reactions (redness, transient discomfort) may occur with subcutaneous administration.
Note: Human clinical data on this specific combination is limited; observations are extrapolated from studies of individual components.
Lifestyle Factors
Complementary strategies for optimal recovery outcomes.
- Pair with adequate protein intake (1.6–2.2 g/kg body weight) to support tissue regeneration.
- Maintain appropriate activity levels; avoid overloading healing tissues while promoting controlled movement.
- Prioritize sleep (7–9 hours) to maximize endogenous repair processes.
- Manage stress through appropriate techniques, as chronic stress impairs healing.
- Stay well-hydrated and maintain balanced micronutrient intake (vitamin C, zinc, collagen precursors).
Injection Technique
General subcutaneous guidance from clinical best-practice resources[6].
- Clean the vial stopper and skin with alcohol; allow to dry completely before proceeding.
- Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[6][10].
- Do not aspirate for subcutaneous injections; inject slowly and steadily[6].
- Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy and local irritation[11].
- Dispose of used syringes in an approved sharps container; never recap or reuse needles.
Recommended Source
We recommend Pure Lab Peptides for high-purity Retatrutide (5 mg vials).
Why Pure Lab Peptides?
- Third-party tested: Each batch includes Certificate of Analysis (COA) verifying purity and composition.
- Consistent quality: ISO-aligned manufacturing and handling standards ensure reliable product integrity.
- Cold-chain integrity: Temperature-controlled shipping and storage throughout fulfillment process.
- Research-grade purity: Suitable for educational and research applications requiring high-quality peptides.
Note: Product availability and specifications subject to change. Verify current product details on supplier website.
Important Note
This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.
References
— Tri-Heal (45 mg) product page; blend composition and specifications
— The regenerative peptide thymosin β4 accelerates dermal healing in preclinical models and patients
— Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
— Orally Targeted Delivery of Tripeptide KPV via HA-Functionalized Nanoparticles Alleviates Ulcerative Colitis
— Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays
— Vaccine Administration: subcutaneous route technique, angle, and site guidance
— Progress on the Function and Application of Thymosin β4
— Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing
— Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and stimulates tendocyte growth
— Technique diagram and site guidance for subcutaneous injections
— Best practices for injection: asepsis, preparation, and administration
— Pharmacologic considerations of the subcutaneous route

![insulin[1] insulin[1]](https://peptidedosing.ca/wp-content/uploads/2026/01/insulin1-178x178.webp)
![Bacteriostatic-Water-Bottle[1] Bacteriostatic-Water-Bottle[1]](https://peptidedosing.ca/wp-content/uploads/2026/01/Bacteriostatic-Water-Bottle1-178x178.webp)
![EasyTouch_Alcohol_Pads[1] EasyTouch_Alcohol_Pads[1]](https://peptidedosing.ca/wp-content/uploads/2026/01/EasyTouch_Alcohol_Pads1-178x178.avif)